| 114.92 BATS BZX Real-Time Price As of 10:07am ET |  +0.58 / +0.51%Today’s Change | 73.69 Today|||52-Week Range 119.84 | +36.06% Year-to-Date |
| Previous close | 114.34 |
| Today’s open | 114.62 |
| Day’s range | 114.40 - 115.15 |
| Volume | 17,641 |
| Average volume (3 months) | 4,175,414 |
| Market cap | $118.9B |
| Earnings growth (last year) | -107.34% |
| Earnings growth (this year) | +30.26% |
| Earnings growth (next 5 years) | +12.60% |
| Revenue growth (last year) | +7.77% |
| P/E ratio | 244.4 |
| Price/Sales | 3.88 |
| Price/Book | 10.65 |
| Today’s change | Today’s % change | |
|---|---|---|
| ABTAbbott Laboratories | +0.39 | +0.54% |
| SNYSanofi | -0.56 | -1.24% |
| ABBVAbbVie | +0.59 | +0.67% |
| AZNAstraZeneca | +0.56 | +1.44% |
| Next reporting date | February 13, 2019 |
| EPS forecast (this quarter) | $1.34 |
| Annual revenue (last year) | $22.9B |
| Annual profit (last year) | -$204.1M |
| Net profit margin | -0.89% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman, President & Chief Executive Officer David A. Ricks |
Senior VP-Biotechnology & Autoimmunity Research Thomas F. Bumol |
Corporate headquarters Indianapolis, Indiana |
